Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 30,000 shares at $80.89 ($2.5M) on 2017-04-25, disclosed to the SEC on 2017-04-27.
Open-market sale of $2.5M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.89 | 5,713 | $462K | 18.8% |
| 2 | $80.89 | 5,713 | $462K | 18.8% |
| 3 | $82.14 | 5,545 | $455K | 18.5% |
| 4 | $82.14 | 5,545 | $455K | 18.5% |
| 5 | $82.87 | 3,742 | $310K | 12.6% |
| 6 | $82.87 | 3,742 |
| $310K |
| 12.6% |
| Total | $81.85 avg | 30,000 | $2.5M | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |